• Top hematology/oncology stories: FDA approves Vitrakvi, ketogenic diet beneficial for ovarian cancer

    5 days ago - By Healio

    Among the top stories in hematology/oncology this past week were the FDA approval of Vitrakvi for solid tumors with neurotrophic receptor tyrosine kinase gene fusion and trial results indicating that the ketogenic diet is superior to the diet recommended by the American Cancer Society for women with ovarian and endometrial cancers.
    Other popular stories included the American Society of Hematology's comprehensive guidelines to improve the management of venous thromboembolism, study results that suggested that the addition of an altitude sickness drug to chemotherapy may improve management
    Read more ...